AURA logo

AURAAura Biosciences Inc

$6.21
$0.09
(1.47%)
Today
Closed $6.21
$0.00
(0.00%)
After Hours
Updated: 06:28 PM EDT
EarningsAug 13
Mkt Cap$632.73M
Vol816,602.00

About

Aura Biosciences, Inc. is a clinical-stage oncology company, which engages in developing a novel technology platform based on virus-like drug conjugates (VDCs) to target and destroy cancer cells selectively while activating the immune system to create long lasting anti-tumor immunity. The firm's product candidate belzupacap sarotalocan (AU-011) is in Phase 2 development for the first line treatment of choroidal melanoma, a vision and life-threatening form of eye cancer where standard of care radioactive treatments leave patients with major vision loss and severe comorbidities. The was founded by Elisabet de los Pinos in 2007 and is headquartered in Boston, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
113

Frequently Asked Questions

What is Market Cap of Aura Biosciences Inc?
What is the 52-week high for Aura Biosciences Inc?
What is the 52-week low for Aura Biosciences Inc?
What is Aura Biosciences Inc stock price today?
What was Aura Biosciences Inc stock price yesterday?
What is the PE ratio of Aura Biosciences Inc?
What is the Price-to-Book ratio of Aura Biosciences Inc?
What is the 50-day moving average of Aura Biosciences Inc?
How many employees does Aura Biosciences Inc have?

Advertisement|Remove ads.